Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2023-08-31 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings
2023-08-31 English
Copy of Newspaper Publication
AGM Information Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a newspaper advertisement about the 76th Annual General Meeting (AGM) to be held via video conferencing. It mentions compliance with SEBI regulations and MCA circulars, and includes details about the AGM date, record date, book closure, and procedural information. The document is short (2251 characters) and primarily serves as an announcement of the AGM and related advertisement, not the AGM materials or minutes themselves. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the AGM or related announcements about the AGM event.
2023-08-28 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an intimation to stock exchanges about the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The content is a notification about upcoming investor conferences and meetings, with no financial data, report content, or detailed analysis. The document length is short (1873 characters) and it serves as an announcement rather than a report or transcript. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-08-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing them about the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The content is about notifying the schedule of investor meetings, not about financial results, reports, or any detailed financial data. The document length is short (1873 characters), and it is an announcement of meetings rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-08-18 English
Strikes/Lockouts/Disturbances
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (National Stock Exchange of India and Bombay Stock Exchange) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) – Regulations, 2015. It provides an update on a previously disclosed fire accident at the company's plant and informs that production operations have resumed. The document is an operational update related to a material event affecting the company, not a financial report, earnings release, or management discussion. It is a regulatory disclosure about a significant event as required by stock exchange regulations. The document length is short (1856 characters), and it is not a report or announcement of a report publication. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-08-04 English
Strikes/Lockouts/Disturbances
Regulatory Filings Classification · 100% confidence The document is a notification addressed to stock exchanges regarding a fire accident at the company's plant. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an incident disclosure rather than a financial report, management discussion, or any other detailed report. The document length is short (2045 characters) and serves as a regulatory announcement of a material event affecting the company. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-07-29 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.